World Library  
Flag as Inappropriate
Email this Article

International Union of Basic and Clinical Pharmacology

Article Id: WHEBN0006494001
Reproduction Date:

Title: International Union of Basic and Clinical Pharmacology  
Author: World Heritage Encyclopedia
Language: English
Subject: G protein-coupled inwardly-rectifying potassium channel, International Council for Science, Guide to Pharmacology, 5-HT1A receptor, 5-HT1D receptor
Publisher: World Heritage Encyclopedia

International Union of Basic and Clinical Pharmacology

International Union of Basic and Clinical Pharmacology
Abbreviation IUPHAR
Formation 1959
Region served
Official language
Parent organization
International Council for Science
Website IUPHAR Official website

The International Union of Basic and Clinical Pharmacology (IUPHAR) is a voluntary, non-profit association representing the interests of scientists in pharmacology-related fields to facilitate Better Medicines through Global Education and Research around the world.


Established in 1959 as a section of the International Union of Physiological Sciences, IUPHAR became an independent organization in 1966[1] and is a member of the International Council for Science (ICSU).[2] The first World Congress of Pharmacology was held in Stockholm, Sweden in 1961 and subsequently held every three years. After 1990 the World Congresses were moved to a four-year interval.[3] These meetings not only present the latest pharmacological advances in research accomplishments, technology, and methodology, but also provide a forum for international collaboration and exchange of ideas. A General Assembly, consisting of delegates from all the member societies, is convened during the congresses so member societies have an opportunity to elect the Executive Committee and vote on matters concerning the governance and activities of the union.


IUPHAR members are regional, national and special interest societies around the world,[4] however, the various sections and committees are composed of individuals from academia, pharmaceutical companies, and government organizations, all working together to advance the field. IUPHAR resources are available to all members of the pharmacology-related societies that adhere to IUPHAR.


IUPHAR is divided in sectional topics. The Division of Clinical Pharmacology focuses on the needs and research tools for clinicians. The Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR) facilitates the interface between the discovery of new sequences from the Human Genome Project and the designation of the derived proteins as functional receptors and ion channels. In other words, as new discoveries are made in pharmacology, NC-IUPHAR provides a uniform guideline for naming and classifying the results in the public domain. Sections specializing in various areas of pharmacology have been established, including Drug Metabolism and Drug Transport,[5] Education,[6] Gastrointestinal Pharmacology,[7] Immunopharmacology,[8] Pharmacology of Natural Products Section,[9] Pediatrics Clinical Pharmacology[10] and Pharmacogenetics and Pharmacogenomics.[11] Volunteers participate in the various sections and division according to their interests and training.


In general, IUPHAR offers individual pharmacologists free curriculum expertise, career development and job listings (the non-profit[12]), research resources, and collaboration opportunities. IUPHAR offers its member societies venues for participating in world-wide initiatives, publicizing member meetings and activities, nominating individuals for Young Investigator awards, and naming delegates to the quadrennial General Assemblies. For examples, visit the biannual newsletter entitled, Pharmacology International at

A primary purpose of IUPHAR is providing global free access to a major, on-line repository of characterization data for G protein-coupled receptors, voltage-gated ion channels, 7TM receptors, nuclear receptors and, shortly, ligand-gated ion channels which are known to be in the human genome. Where relevant, data on the rat and mouse homologues are presented to assist researchers and clinicians in developing and/or enhancing therapeutics for eventual medication for humans.

NC-IUPHAR also promulgates standards of name nomenclature for research in pharmacology and the related disciplines.

As a essential medicines, appropriate dose therapeutics for children, and clinical pharmacology core competencies among its many WHO-related activities.

The Division of Clinical Pharmacology compiled and released the Research in Humans Compendium,[13] a free resource to provide the scientific community interested in human research with an easy-to-use reference on how to design a research protocol to assess the effectiveness of a drug in a series of pathological conditions.

An important aspect of IUPHAR is the development of pharmacology in Three Rs.

Future directions

The early years of the 21st century will be focused on integrating basic and clinical research into a continuous spectrum of investigation to implement translational medicine techniques more quickly. The 9th World Conference on Clinical Pharmacology and Therapeutics in Québec City, Canada was the last IUPHAR meeting to present clinical pharmacology separately. The WorldPharma2010 - World Congress of Basic and Clinical Pharmacology in Copenhagen, Denmark on July 17–23, 2010 was the first completely integrated meeting. The expectation of merging these different approaches to the same discipline is to more quickly discover, devise, test and introduce new or higher quality therapeutics for humans.

Educational components will be emphasized for both existing pharmacology programs as well as increasing and enhancing pharmacology training in developing countries. This topic was a central theme of the 17th World Congress of Basic and Clinical Pharmacology (WCP2014) held July 13–18, 2014 in Cape Town, South Africa. Additionally, the 18th World Congress of Basic and Clinical Pharmacology (WCP2018) being held in Kyoto, Japan on July 1–6, 2018 will focus on drug development and therapeutics using revolutionary methodologies such as genome sequencing, stem cell biology, nanotechnology and systems biology. ..

See also


  1. ^
  2. ^
  3. ^
  4. ^
  5. ^
  6. ^
  7. ^
  8. ^
  9. ^
  10. ^
  11. ^
  12. ^
  13. ^

External links

  • International Union of Basic and Clinical Pharmacology (IUPHAR)
  • The Guide to Pharmacology
  • NC-IUPHAR Nomenclature Guidelines
  • The 18th World Congress of Basic and Clinical Pharmacology
  • A)fPharmacology for Africa Initiative (Phar
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.